<DOC>
	<DOCNO>NCT01973244</DOCNO>
	<brief_summary>This trial conduct Europe Asia . The aim trial investigate safety , tolerability , pharmacokinetics ( exposure trial drug body ) pharmacodynamics ( effect investigate drug body ) single dose long-acting growth hormone ( NNC0195-0092 ) compare daily dose Norditropin速 SimpleXx速 ( somatropin ) child growth hormone deficiency .</brief_summary>
	<brief_title>A Trial Investigating Safety , Tolerability , Pharmacokinetics Pharmacodynamics Single Dose Long-acting Growth Hormone Compared Daily Dosing Norditropin速 SimpleXx速 Children With Growth Hormone Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Confirmed diagnosis GHD ( growth hormone deficiency ) define two different GH ( growth hormone ) stimulation test , peak GH level equal 7.0 ng/ml . For child three pituitary hormone deficiencies one GH stimulation test need . If accordance country specific practice , growth hormone deficiency define one GH stimulation test , peak GH level equal 7.0 ng/ml . Prepubertal child screen . Boys : Tanner stage 1 age equal 6 year 13 year . Girls : Tanner stage 1 age equal 6 year 12 year Body weight equal 16.0 kg equal 50.0 kg Stable GH replacement treatment least 3 month History presence malignancy Overt diabetes mellitus ( fast blood glucose equal 7.0 mmol/l )</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>13 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>